Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Zeev Bronfeld currently holds 2,162,481 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Zeev Bronfeld has been a net seller of PLX stock. They have purchased $250.0K and sold $11.1M worth of shares.
Zeev Bronfeld's most recent insider trade was on Oct 2, 2014, when they sold 324,372 shares at $0.00 per share.
Zeev Bronfeld serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 10 insider transactions totaling $11.3M over their tenure at the company.
Zeev Bronfeld holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Zeev Bronfeld has shown a selling trading pattern, with $250.0K in total purchases and $11.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Zeev Bronfeld was on Aug 13, 2014, when they sold $10.9M worth of PLX shares. This transaction involved 4,400,000 shares at $2.47 per share.
Zeev Bronfeld currently owns 2,162,481 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Zeev Bronfeld's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Zeev Bronfeld has 10 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for Zeev Bronfeld and 40,000+ other insiders.